Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Basic Science Updates

Saturday, November 11, 2023
11:10 AM – 11:20 AM CST
Location: Legends ABCD

    Speaker(s)

  • Randy Sweis, MD

    University of Chicago
    University of Chicago
    Chicago, Illinois, United States

    Disclosure(s): Contract Research: Abbvie (Ongoing); Ascendis (Ongoing); Astellas (Ongoing); Astra Zeneca (Ongoing); BMS (Ongoing); CytomX (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Genentech/Roche (Ongoing); Gilead (Ongoing); Immunocore (Ongoing); Lilly (Ongoing); Merck (Ongoing); Mirati Therapeutics (Ongoing); Moderna (Ongoing); Novartis (Ongoing); Pfizer (Ongoing); Pionyr (Ongoing); Pyxis Oncology (Ongoing); QED Therapeutics (Ongoing); Scholar Rock (Ongoing); Seattle Genetics (Ongoing)
    Non-CE Consulting: Astellas (Ongoing); Astra Zeneca (Ongoing); Aveo (Ongoing); BMS (Ongoing); Editas (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Exelixis (Ongoing); Gilead (Ongoing); Janssen (Ongoing); Lilly (Ongoing); Mirati Therapeutics (Ongoing); Pfizer (Ongoing); Seattle Genetics (Ongoing); Silverback (Ongoing)
    Ownership Interest: I own stocks of the Commercial entity: Abbvie (Ongoing)

    Slides
Disclosure(s):
Randy Sweiss, MD, PhD: Contract Research: Abbvie (Ongoing); Ascendis (Ongoing); Astellas (Ongoing); Astra Zeneca (Ongoing); BMS (Ongoing); CytomX (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Genentech/Roche (Ongoing); Gilead (Ongoing); Immunocore (Ongoing); Lilly (Ongoing); Merck (Ongoing); Mirati Therapeutics (Ongoing); Moderna (Ongoing); Novartis (Ongoing); Pfizer (Ongoing); Pionyr (Ongoing); Pyxis Oncology (Ongoing); QED Therapeutics (Ongoing); Scholar Rock (Ongoing); Seattle Genetics (Ongoing)
Non-CE Consulting: Astellas (Ongoing); Astra Zeneca (Ongoing); Aveo (Ongoing); BMS (Ongoing); Editas (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Exelixis (Ongoing); Gilead (Ongoing); Janssen (Ongoing); Lilly (Ongoing); Mirati Therapeutics (Ongoing); Pfizer (Ongoing); Seattle Genetics (Ongoing); Silverback (Ongoing)
Ownership Interest: I own stocks of the Commercial entity: Abbvie (Ongoing)